Skip to main content
SGMOQ logo

SGMOQ · Sangamo Therapeutics, Inc · Documents

Track SGMOQ — free
$0.11 +0.00 (+0.00%) At close · Nov 18 Play latest call Q1 2026 earnings call transcript
Market Cap
$45.57M
Shares
414.29M
Volume · Nov 18 211.89K Avg daily vol (3M) 1.65M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024
Mar 13
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $176.23M ▲ 58.3% Net loss $257.83M Diluted EPS -$1.48
2023
Feb 23
Annual report 10-K FY2022, ended Dec 31
Annual report for FY2022
Revenue $111.3M ▲ 0.5% Net loss $192.28M Diluted EPS -$1.25
2022
Showing 51–100 of 161 documents
Key facts CIK 1001233 CUSIP 800677106 13F (30d) 21 filings 4 filers Visit website Investor relations